JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited (JSP) Stock Statistics & Valuation Metrics

JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited has a market cap or net worth of THB 792.54M. The enterprise value is THB 1.30B.

Market Cap

THB 792.54M

Enterprise Value

THB 1.30B

JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited has 474,574,920 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

474,574,920

Owned by Insiders

―

Owned by Institutions

―

JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 2.30%.

Return on Equity (ROE)

0.07

Return on Assets (ROA)

0.05

Return on Invested Capital (ROIC)

2.30%

Return on Capital Employed (ROCE)

0.06

Revenue Per Employee

3.74M

Profits Per Employee

251.36K

Employee Count

270

Asset Turnover

0.69

Inventory Turnover

5.96

The current PE Ratio of JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited is 18.47. JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited’s PEG ratio is 0.36.

PE Ratio

18.47

PS Ratio

0.83

PB Ratio

0.89

Price to FCF

-4.62

Price to Operating Cash Flow

7.43

PEG Ratio

0.36

In the last 12 months, JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited had revenue of 1.01B and earned 67.87M in profits. Earnings per share was 0.14.

Revenue

1.01B

Gross Profit

405.55M

Operating Income

68.01M

Pretax Income

100.00M

Net Income

67.87M

EBITDA

137.52M

Earnings Per Share (EPS)

0.14

In the last 12 months, operating cash flow was 106.60M and capital expenditures -278.12M, giving a free cash flow of -171.52M billion.

Operating Cash Flow

106.60M

Free Cash Flow

-171.52M

Free Cash Flow per Share

-0.36

JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited pays an annual dividend of ―, resulting in a dividend yield of 4.11%

Dividend Per Share

―

Dividend Yield

4.11%

Payout Ratio

N/A

Free Cash Flow Yield

-21.64%

Earnings Yield

5.42%

Beta

0.30

52-Week Price Change

2.45%

50-Day Moving Average

―

200-Day Moving Average

―

Relative Strength Index (RSI)

40.56

Average Volume (3m)

86.26K

JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited upcoming earnings date is Nov 16, 2026, TBA (Not Confirmed).

Last Earnings Date

May 15, 2026

Next Earnings Date

Nov 16, 2026

Ex-Dividend Date

―

JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited as a current ratio of 1.39, with Debt / Equity ratio of 41.95%

Current Ratio

1.39

Quick Ratio

0.96

Debt to Market Cap

0.37

Net Debt to EBITDA

2.42

Interest Coverage Ratio

4.67

In the past 12 months, JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited has paid 54.84M in taxes.

Income Tax

54.84M

Effective Tax Rate

0.55

JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited EV to EBITDA ratio is 9.14, with an EV/FCF ratio of -6.63.

EV to Sales

1.19

EV to EBITDA

9.14

EV to Free Cash Flow

-6.63

EV to Operating Cash Flow

10.67

JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited has THB 42.84M in cash and marketable securities with THB 388.03M in debt, giving a net cash position of -THB 345.19M billion.

Cash & Marketable Securities

THB 42.84M

Total Debt

THB 388.03M

Net Cash

-THB 345.19M

Net Cash Per Share

-THB 0.73

Tangible Book Value Per Share

THB 1.85

Gross margin is 38.38%, with operating margin of 6.05%, and net profit margin of 4.49%.

Gross Margin

38.38%

Operating Margin

6.05%

Pretax Margin

7.46%

Net Profit Margin

4.49%

EBITDA Margin

13.01%

EBIT Margin

5.89%

The average price target for JSP Pharmaceutical Manufacturing (Thailand) Public Company Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-0.36%

EPS Growth Forecast

50.92%